A clinical trial to study the effects of two skin antiseptics,Chlorhexidine and Povidone-Iodine(Betadine) in women undergoing emergency cesarean delivery.

Phase 2

Not yet recruiting

Brief Summary: This study is a randomized, double blind, parallel group, active controlled trial comparing the efficacy of chlorhexidine gluconate and povidone iodine as skin antiseptic for prevention of surgical site infection in women undergoing emergency caesarean delivery expecting chlorhexidineâ€“gluconate to be superior to povidine iodine in having less incidence of SSI. The primary outcome measures will be the incidence of Surgical Site Infection. The secondary outcome measures will be the duration of hospital stay, requirement for re-suturing, re-admission resulting from infection, pyrexia.

Recruitment & Eligibility

Inclusion Criteria

Antenatal women at â‰¥34 weeks gestational age undergoing emergency Cesarean delivery.

Exclusion Criteria

1)Patients denying consent 2)Known allergy to one or both of the agents.
3)Patients with skin lesions adjacent to the operative site.
4)Women with chorioamnionitis, pyelonephritis, urinary tract infection, and mastitis.

Primary Outcome Measures

Name	Time	Method
To estimate the incidence of surgical site infection with use of Chlorhexidinegluconate compared with povidone iodine as skin antiseptic in women undergoing emergency caesarean delivery.	followed postoperatively after 48 hours,1 week and 30 days.

Secondary Outcome Measures

Name	Time	Method
To compare the incidence of the below outcomes	1)Duration of hospital stay.

Locations (1): All India Institute of Medical Sciences,Bhubaneswar
🇮🇳
Khordha, ORISSA, India
All India Institute of Medical Sciences,Bhubaneswar
🇮🇳Khordha, ORISSA, India
Gabbeta Spandana
Principal investigator
8008186286
gabbetaspandana94@gmail.com